Abstract
6009 Background: Although we recently observed that introducing palliative care soon after diagnosis for patients with metastatic NSCLC is associated with better quality of life, mood, and survival, the degree to which this care model impacts medical treatment at the end of life requires further study. The aim of this follow-up analysis was to examine the effect of early palliative care on the frequency and timing of chemotherapy utilization and hospice care among patients with metastatic NSCLC. Methods: In this randomized controlled trial, we enrolled 151 patients with newly-diagnosed, metastatic NSCLC presenting to the Massachusetts General Hospital Cancer Center between 6/06 and 7/09. We randomly assigned patients within eight weeks after diagnosis to receive early palliative care integrated with standard oncology care (N=77) or standard oncology care alone (N=74). Participants in the intervention group consulted with palliative care clinicians at least monthly until death. Using Fisher’s exact and log...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
